Skip to main navigation
  • Overview
  • Press Releases
  • Events & Presentations
    • Upcoming Events
    • Past Events
    • Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Documents & Charters
  • Financial Information
  • Stock Information
    • Stock Quote & Chart
    • Historical Price
    • Investment Calculator
  • Shareholder Services
    • Investor FAQs
    • Document Request
    • Contact IR
  • Back to CRISPR »

Presentations

Presentations

Jan 2021
CRISPR Tx Corporate Overview – January 2021 1.5 MB
Dec 2020
Phase 1/2 CTX001™ Investor Update Presentation 902.7 KB
Dec 2020
2020 ASH Meeting and Exposition Presentation 2.8 MB
Oct 2020
Phase 1 CARBON Top-Line Data Presentation 1.2 MB
Jun 2020
2020 AACR II Virtual Meeting Poster: Functional and single-cell assessment of CRISPR-modified CAR-T cells from NSCLC patients and healthy donors 466.7 KB
Jun 2020
2020 AACR II Virtual Meeting Poster: Allogeneic CAR-T cell products containing 10 gene edits using CRISPR/Cas9 can retain full functionality in vivo and in vitro 522.4 KB
Jun 2020
2020 AACR II Virtual Meeting Poster: Allogeneic anti-PTK7 CAR-T cells for the treatment of solid tumors 628.8 KB
Jun 2020
2020 AACR II Virtual Meeting Poster: Targeting T cell lymphomas with CRISPR/Cas9-generated anti-CD70 allogeneic CAR-T cells 415.8 KB
Jun 2020
2020 European Hematology Association (EHA) Congress Presentation 1.4 MB
May 2020
2020 ASGCT Annual Meeting Poster: Dual Guide CRISPR/Cas9 Editing of the CCR5 Gene Provides Complete Protection Against HIV in Humanized Mouse Models 249.4 KB

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 23

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR

Interested in joining our team? Careers at CRISPR

© 2021 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions